Jenburkt Pharmaceuticals Limited, based in India, specializes in manufacturing and marketing pharmaceutical formulations and healthcare products under two divisions: consumer and pharmaceutical. They have a diverse product portfolio with approximately 50 brands promoted through doctors.

Jenburkt Pharma major competitors are Medicamen Biotech, Albert David, Fredun Pharma, Brooks Laboratories, Kilitch Drugs(India), Zim Laboratories, Venus Remedies.
Market Cap of Jenburkt Pharma is ₹502 Crs.
While the median market cap of its peers are ₹469 Crs.

Jenburkt Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.